Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correction (v156,p553)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosen, B. R.
Right arrow Articles by Brady, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosen, B. R.
Right arrow Articles by Brady, T. J.

Radiology, Vol 154, 469-472, Copyright © 1985 by Radiological Society of North America


ARTICLES

Proton chemical shift imaging: an evaluation of its clinical potential using an in vivo fatty liver model

BR Rosen, EA Carter, IL Pykett, BR Buchbinder and TJ Brady

The potential laboratory and clinical utility of proton chemical shift imaging (PCSI) was evaluated by studying fatty liver change in rats, which offered a simple animal model for tissue lipid buildup. There was excellent correlation between lipid group signal intensities from in vivo PCSI studies and liver triglyceride levels obtained from in vitro measurements (R = 0.97). The in vivo T1 relaxation time measurements in fatty liver tissue demonstrated two distinct populations of nonexchanging protons. We explain the reason for the lack of sensitivity in conventional magnetic resonance (MR) imaging studies of fatty liver change and discuss the implications of our findings for MR imaging studies of other tissues. PCSI promises improved diagnostic sensitivity and specificity in studying a wide range of human pathologic conditions.


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
C. G. Lall, A. M. Aisen, N. Bansal, and K. Sandrasegaran
Nonalcoholic Fatty Liver Disease
Am. J. Roentgenol., April 1, 2008; 190(4): 993 - 1002.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. K. Hussain, T. L. Chenevert, F. J. Londy, V. Gulani, S. D. Swanson, B. J. McKenna, H. D. Appelman, S. Adusumilli, J. K. Greenson, and H. S. Conjeevaram
Hepatic Fat Fraction: MR Imaging for Quantitative Measurement and Display--Early Experience
Radiology, December 1, 2005; 237(3): 1048 - 1055.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1985 by the Radiological Society of North America.